The startup intends to make a small patch pump with a closed-loop algorithm for nighttime glucose control.

Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.

The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.

The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being ...

O’Hara joins CMR’s executive team as commercial president and general manager for the U.S., following the FDA’s authorization ...

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott ...

New limits to the program could force hospitals to slash capital spending while bracing for millions of newly uninsured ...

Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by ...

July and August have brought a steady beat of private financings for young medtech companies, with several deals supporting ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused ...

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.